Barclays raised the firm’s price target on HCA Healthcare (HCA) to $494 from $445 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q3 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $525 from $495 at UBS
- HCA Healthcare price target raised to $520 from $470 at Goldman Sachs
- HCA Healthcare price target raised to $425 from $400 at Morgan Stanley
- HCA Healthcare price target raised to $525 from $444 at Cantor Fitzgerald
- HCA Healthcare price target raised to $500 from $400 at Oppenheimer